据报道 Semler Scientific 购买了价值 2150 万美元的比特币

据报道，一家通过其技术解决方案 Semler Scientific 在慢性病管理领域处于领先地位的知名公司将根据该公司的长期财务计划购买价值 2150 万美元的比特币。

Semler Scientific (NYSE: SMLR), a company renowned for its technological solution in chronic condition management, is reportedly deploying an additional $21.5 million in Bitcoin (BTC) as part of its long-term financial strategy. This latest purchase aligns with the company's broader commitment to a BTC treasury program, which was launched earlier in 2024.

Semler Scientific（纽约证券交易所股票代码：SMLR）是一家以其慢性病管理技术解决方案而闻名的公司，据报道，作为其长期财务战略的一部分，该公司将额外部署 2150 万美元的比特币 (BTC)。此次最新购买符合该公司对 2024 年初推出的 BTC 金库计划的更广泛承诺。

According to the recent filing, Semler Scientific has calculated the purchase of 211 Bitcoins, averaging at a market value of $101,890, for a total cost of $21.5 million. The company has also showcased impressive growth in Bitcoin yield with this purchase, reporting a quarterly yield of 67.0%, bringing its total yield to 92.8% since implementing the BTC treasury plan in May 2024.

根据最近提交的文件，Semler Scientific 计算出购买了 211 个比特币，平均市场价值为 101,890 美元，总成本为 2150 万美元。通过此次购买，该公司的比特币收益率也实现了令人印象深刻的增长，季度收益率为 67.0%，自 2024 年 5 月实施 BTC 国库计划以来，其总收益率达到 92.8%。

Semler's Bitcoin Drive Pushes Up Available Shares

塞姆勒的比特币推动推高了可用股票

The company's strategy, which now includes 2,084 BTC at a cost of $168.6 million, highlights the increasing trend of cryptocurrency forming a substantial part of capital markets strategy. This is especially noteworthy for a company focused on chronic illness technology solutions, actively pursuing diversification.

该公司的战略目前包括 2,084 比特币，成本为 1.686 亿美元，凸显了加密货币日益成为资本市场战略重要组成部分的趋势。对于一家专注于慢性病技术解决方案、积极追求多元化的公司来说，这一点尤其值得注意。

Semler Scientific increased its maximum available shares under the at-the-market (ATM) offering to $150 million, effective December 16, 2024. The firm had achieved $100 million by December 13, 2024. It also entered an agreement with Cantor Fitzgerald & Co. to use a Controlled Equity Offering.

Semler Scientific 将其在市场 (ATM) 发行下的最大可用股票增加至 1.5 亿美元，自 2024 年 12 月 16 日起生效。截至 2024 年 12 月 13 日，该公司的股票发行额已达到 1 亿美元。该公司还与 Cantor Fitzgerald & Co 达成协议. 使用受控股权发行。

With the Bitcoin addition, Semler has also significantly increased its share count. The outstanding shares have increased from 6.99 million in June 2024 to 9.27 million as of December 2024. The diluted shares came to 9.97 million. Semler noted that while this has increased, multiple factors impact the stock price. He highlighted that the value of the Bitcoins owned is only one of those factors.

随着比特币的加入，Semler 的股份数量也大幅增加。已发行股份从2024年6月的699万股增加到截至2024年12月的927万股。稀释后的股份达到997万股。塞姆勒指出，虽然这一数字有所增加，但影响股价的因素有多种。他强调，所拥有的比特币的价值只是这些因素之一。

Semler continues to showcase a commitment to its cryptocurrency strategy, considering it an essential element of its overall financial vision. However, the company clarifies its BTC Yield as not a measure of performance results for shareholders. It guides management by showing which strategy has been initiated to help achieve long-term shareholder value.

Semler 继续展示对其加密货币战略的承诺，认为这是其整体财务愿景的重要组成部分。然而，该公司澄清其比特币收益率并不是衡量股东业绩的指标。它通过显示已启动哪些策略来帮助实现长期股东价值来指导管理层。

MicroStrategy is a large entity, it holds a lot of Bitcoin, but the more critical consideration is in the strategic standpoint, and for Semler Scientific, the focus still leans on Bitcoin as the strong foundation of its long-run growth.

MicroStrategy是一个庞大的实体，它持有大量的比特币，但更关键的考虑是在战略角度，而对于Semler Scientific来说，重点仍然依靠比特币作为其长期增长的坚实基础。